Data Justified Cymbalta Risk Warnings, Eli Lilly Says
An Eli Lilly & Co. official refuted allegations at a Virginia federal jury trial Monday that it hid the withdrawal risks of antidepressant drug Cymbalta, saying the company accurately used data...To view the full article, register now.
Already a subscriber? Click here to view full article